Premium
Recognition of the toxicity of aristolochic acid
Author(s) -
Zhang HongMei,
Zhao XiaoHu,
Sun ZhiHui,
Li GuiChen,
Liu GuangChen,
Sun LiRui,
Hou JiQiu,
Zhou Wei
Publication year - 2019
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12789
Subject(s) - aristolochic acid , aristolochia , toxicity , aristolochiaceae , nephrotoxicity , carcinogen , traditional medicine , medicine , nephropathy , toxicology , pharmacology , biology , biochemistry , genetics , endocrinology , botany , diabetes mellitus
Summary What is Known and Objective Aristolochic acid (AA) is an abundant compound in Aristolochia plants and various natural herbs. In the 1990s, a slimming formula used in Belgium that contains Aristolochia fangchi was reported to cause kidney damage and bladder cancer, and aristolochic acid nephropathy (AAN) is now well recognized worldwide. In October 2017, researchers reported an AA signature that is closely associated with hepatocellular carcinoma (HCC) worldwide. Comment There are differing opinions on the toxicity of AA, and different countries have taken different measures to address the issue. There is a lack of clarity on the causal role of AA in hepatocarcinogenesis and on the potential underlying mechanisms for the reported nephrotoxicity and carcinogenicity. The toxicity of AA differs depending on gender and age, and other risk factors that could explain the variability in the toxicity of AA remain to be identified. What is New and Conclusion Whether preparations containing AA, such as many Chinese medicines, should be used remains controversial, and this issue warrants further investigation before definite conclusions can be drawn.